TY  - JOUR
AU  - Grothey, Axel
AU  - Yoshino, Takayuki
AU  - Bodoky, Gyorgy
AU  - Ciuleanu, Tudor
AU  - Garcia-Carbonero, Rocio
AU  - García-Alfonso, Pilar
AU  - Van Cutsem, Eric
AU  - Muro, Kei
AU  - Mytelka, Daniel S
AU  - Li, Li
AU  - Lipkovich, Olga
AU  - Hsu, Yanzhi
AU  - Sashegyi, Andreas
AU  - Ferry, David
AU  - Nasroulah, Federico
AU  - Tabernero, Josep
PY  - 2018
DO  - 10.1136/esmoopen-2018-000347
SN  - 2059-7029
UR  - https://hdl.handle.net/10668/25594
T2  - ESMO open
AB  - In the RAISE trial, ramucirumab+leucovorin/fluorouracil/irinotecan (FOLFIRI) improved the median overall survival (mOS) of patients with previously treated metastatic colorectal cancer versus patients treated with placebo+FOLFIRI but had a higher...
LA  - en
KW  - bevacizumab
KW  - electronic medical records
KW  - neutropenia
KW  - prognostic
KW  - ramucirumab
TI  - Association of baseline absolute neutrophil counts and survival in patients with metastatic colorectal cancer treated with second-line antiangiogenic therapies: exploratory analyses of the RAISE trial and validation in an electronic medical record data set.
TY  - research article
VL  - 3
ER  -